Videos de Experimentos Relacionados
Diferencias farmacocinéticas entre grupos étnicos.
Lancet (London, England)
|January 26, 2002
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Gene expression and linkage analysis implicate CBLB as a mediator of rituximab resistance.
The pharmacogenomics journal·2017
Same author
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy.
Clinical pharmacology and therapeutics·2016
Same author
Budget Impact Analysis of CYP2C19 Genotyping to Target Voriconazole Prophylaxis During Induction-Consolidation Therapy in Acute Myeloid Leukemia (AML) in The United States.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author
Integrated patient and tumor genetic testing for individualized cancer therapy.
Clinical pharmacology and therapeutics·2015
Same author
Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting.
Clinical pharmacology and therapeutics·2015
Same author
Carboplatin/taxane-induced gastrointestinal toxicity: a pharmacogenomics study on the SCOTROC1 trial.
The pharmacogenomics journal·2015
Same journal
Convergence of metabolic risk in obesity and normal BMI: does risk disappear?
Lancet (London, England)·2026
Same journal
Metabolic traits in obesity and normal BMI in industrialised countries: a multi-country analysis of national population-based studies.
Lancet (London, England)·2026
Same journal
Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.
Lancet (London, England)·2026
Same journal
The US Ebola response and the future of global health leadership.
Lancet (London, England)·2026
Same journal
The 2026 Wakley-Wu Lien Teh Prize Essay: why medicine, and why stay?
Lancet (London, England)·2026